Loss of Cell Identity Drives Human Aging

Two recent papers propose that aging is driven not only by cumulative damage but by progressive loss of cell identity caused by erosion of epigenetic architecture. Cells maintain identity through a three-tier regulatory grammar: fast transcriptional responses, intermediate state transitions, and a slow, chromatin-based layer that locks identity. Polycomb repressive complex 2 (PRC2) sculpts that slow layer; chronic inflammation and other persistent stressors undermine PRC2-mediated constraints, producing decanalization of Waddington’s landscape. Epigenetic clocks - accurate across 348 mammalian species - track erosion of PRC2 low-methylated regions, and widespread “mesenchymal drift,” a shift toward fibroblast-like states, has been documented in 46 tissue types and linked to fibrosis, inflammation, and age-related diseases from atherosclerosis to Alzheimer’s.

That mechanistic insight points to interventions to preserve or restore identity. Caloric restriction preserves slow-layer architecture via reduced acetyl-CoA and PRC2 effects. Partial epigenetic reprogramming with transient Yamanaka factor exposure (OSKM) or OSK-only regimens reverses identity loss in aged cells and animal models but risks tumorigenesis if full reprogramming occurs; OSK is already being trialed for optic nerve damage. Lithium and GSK3β modulation show neuron-preserving effects and reduced tau phosphorylation. Lifestyle factors that chronically stress the fast layer (pro-inflammatory diet, inactivity, poor sleep) accelerate slow-layer erosion. Safety and efficacy of systemic identity-restoring therapies in humans remain unproven, but the framework reframes aging as an epigenetic collapse amenable to targeted interventions.